Showing articles whose micro-themes are very close to:
#von Hippel-Lindau
- No closely related articles found yet.
- NCPE Recommends Against Reimbursement of Belzutifan (Welireg) for von Hippel-Lindau Disease in Ireland (ncpe.ie) | 15d ago
- NCPE Recommends Belzutifan (Welireg) Not Reimbursed for VHL Disease on Cost-Effectiveness Grounds (ncpe.ie) | 39d ago
- NCPE Assessment: Belzutifan not cost-effective for VHL disease-associated tumours at current price (ncpe.ie) | 39d ago
Showing page 1 of 1
(3 total results)
← Prev
Next →